Position in PYXS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$444,509
-$459,402 QoQ
Shares Held
304,459
-61.3% QoQ
Ownership
0.481%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 78 holders
Holding Since
Mar 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PYXS Over Time
Shares Held
Position Value (USD)
Derivatives in PYXS
reported options exposure · as of Mar 31, 2026CallValue
$37,230
CallShares
25,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026JANE STREET GROUP, LLC holds $1,247,243,084 across 314 Biotechnology names. PYXS ranks #167 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,757,672 | $130,524,721 | |
| 2 | RPRX |
Royalty Pharma plc
|
2,400,382 | $115,146,324 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
2,041,669 | $67,824,242 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
122,946 | $54,900,305 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
831,707 | $53,753,223 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,087,030 | $46,622,715 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
223,615 | $42,274,415 | |
| 8 | BNTX |
BioNTech SE
|
336,757 | $29,930,962 |
All Filings in PYXS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,230 | 25,500 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $444,509 | 304,459 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $903,911 | 786,010 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $674,213 | 303,700 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $369,692 | 336,084 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $105,589 | 67,686 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $181,876 | 49,558 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $116,541 | 35,209 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $746,573 | 175,252 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $27,028 | 15,016 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $302,474 | 75,430 | Shares | Defined | 2023-05-16 | |
| No filing history on record for this holder in this stock. | ||||||